Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile.

MedStar author(s):
Citation: JAMA Dermatology. 157(11):1381-1383, 2021 11 01.PMID: 34643656Institution: MedStar Washington Hospital CenterDepartment: Medical Dermatology ResidencyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Pityriasis Lichenoides | Antibodies, Monoclonal, Humanized | Cytokines | Herpes Simplex | Humans | Nitriles | Pityriasis Lichenoides/th [Therapy] | Pyrazoles | PyrimidinesYear: 2021ISSN:
  • 2168-6068
Name of journal: JAMA dermatologyAll authors: Brooks J, DiLorenzo A, Habeshian K, Keller MD, Kirkorian AY, Lotke M, Wu ROriginally published: JAMA Dermatology. 157(11):1381-1383, 2021 Nov 01.Fiscal year: FY2022Digital Object Identifier: Date added to catalog: 2022-01-25
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 34643656 Available 34643656

English

Powered by Koha